(EHTH) eHealth - Ratings and Ratios
Medicare Plans, Individual Plans, Marketplace Platform, Lead Services
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 78.8% |
| Value at Risk 5%th | 105% |
| Relative Tail Risk | -19.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -76.76 |
| CAGR/Max DD | -0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.358 |
| Beta | 1.608 |
| Beta Downside | 1.277 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.18% |
| Mean DD | 37.89% |
| Median DD | 41.58% |
Description: EHTH eHealth November 16, 2025
eHealth, Inc. (NASDAQ:EHTH) runs a digital health-insurance marketplace that connects U.S. consumers with a range of Medicare and non-Medicare plans, offering education, comparison tools, and enrollment services through a suite of branded websites (eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, GoMedigap.com).
The business is split into two operating segments. The Medicare segment sells Medicare Advantage, Medicare Supplement, and Part D prescription drug plans, and also markets ancillary products such as dental and vision coverage, while providing advertising and ancillary services to plan sponsors. The Employer & Individual segment targets non-Medicare-eligible customers, offering individual, family, and small-business health policies plus ancillary and short-term products.
Beyond plan sales, eHealth delivers e-commerce and consumer-engagement solutions that include decision-support tools, lead generation, technology licensing, and post-enrollment services. These capabilities are packaged as non-broker-of-record referrals, online sponsorship, and advertising arrangements, allowing insurers to reach shoppers in an objective, data-driven environment.
According to the company’s most recent quarterly filing (Q2 2024), eHealth generated approximately $274 million in revenue, reflecting a 12% year-over-year increase driven largely by higher Medicare enrollment and growth in its digital advertising business. The broader health-insurance brokerage sector is benefitting from an aging U.S. population-Medicare enrollment is projected to rise at a 2.5% annual rate through 2030-and from continued consumer migration toward online plan shopping, a trend accelerated by the COVID-19 pandemic. However, the company’s profitability remains sensitive to regulatory changes in the Medicare Advantage marketplace and to competitive pressure from larger insurers that are expanding their own direct-to-consumer platforms.
For a deeper quantitative assessment, you may explore ValueRay’s detailed earnings model for EHTH.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (50.3m TTM) > 0 and > 6% of Revenue (6% = 32.6m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 0.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.34% (prev 61.74%; Δ -15.39pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -17.1m <= Net Income 50.3m (YES >=105%, WARN >=100%) |
| Net Debt (29.6m) to EBITDA (71.6m) ratio: 0.41 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.6m) change vs 12m ago 3.89% (target <= -2.0% for YES) |
| Gross Margin 85.96% (prev 99.76%; Δ -13.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.99% (prev 46.40%; Δ 6.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.71 (EBITDA TTM 71.6m / Interest Expense TTM 10.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.53
| (A) 0.24 = (Total Current Assets 302.9m - Total Current Liabilities 51.2m) / Total Assets 1.05b |
| (B) -0.04 = Retained Earnings (Balance) -43.8m / Total Assets 1.05b |
| (C) 0.06 = EBIT TTM 57.2m / Avg Total Assets 1.02b |
| (D) -0.27 = Book Value of Equity -43.9m / Total Liabilities 162.9m |
| Total Rating: 1.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.17
| 1. Piotroski 3.50pt |
| 2. FCF Yield -20.02% |
| 3. FCF Margin -5.50% |
| 4. Debt/Equity 0.10 |
| 5. Debt/Ebitda 0.41 |
| 6. ROIC - WACC (= -1.07)% |
| 7. RoE 6.07% |
| 8. Rev. Trend -13.48% |
| 9. EPS Trend -5.86% |
What is the price of EHTH shares?
Over the past week, the price has changed by -0.95%, over one month by +14.96%, over three months by +0.24% and over the past year by -48.38%.
Is EHTH a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EHTH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.5 | 104.8% |
| Analysts Target Price | 8.5 | 104.8% |
| ValueRay Target Price | 3.7 | -10.1% |
EHTH Fundamental Data Overview December 18, 2025
P/E Trailing = 26.75
P/E Forward = 4.2088
P/S = 0.2425
P/B = 0.2579
P/EG = 0.7211
Beta = 1.268
Revenue TTM = 543.0m USD
EBIT TTM = 57.2m USD
EBITDA TTM = 71.6m USD
Long Term Debt = 69.4m USD (from longTermDebt, last quarter)
Short Term Debt = 7.77m USD (from shortTermDebt, last quarter)
Debt = 92.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.6m USD (from netDebt column, last quarter)
Enterprise Value = 149.1m USD (131.7m + Debt 92.7m - CCE 75.3m)
Interest Coverage Ratio = 5.71 (Ebit TTM 57.2m / Interest Expense TTM 10.0m)
FCF Yield = -20.02% (FCF TTM -29.8m / Enterprise Value 149.1m)
FCF Margin = -5.50% (FCF TTM -29.8m / Revenue TTM 543.0m)
Net Margin = 9.27% (Net Income TTM 50.3m / Revenue TTM 543.0m)
Gross Margin = 85.96% ((Revenue TTM 543.0m - Cost of Revenue TTM 76.2m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 38.76%)
Tobins Q-Ratio = 0.14 (Enterprise Value 149.1m / Total Assets 1.05b)
Interest Expense / Debt = 2.57% (Interest Expense 2.38m / Debt 92.7m)
Taxrate = 26.18% (-11.2m / -42.9m)
NOPAT = 42.3m (EBIT 57.2m * (1 - 26.18%))
Current Ratio = 5.91 (Total Current Assets 302.9m / Total Current Liabilities 51.2m)
Debt / Equity = 0.10 (Debt 92.7m / totalStockholderEquity, last quarter 884.5m)
Debt / EBITDA = 0.41 (Net Debt 29.6m / EBITDA 71.6m)
Debt / FCF = -0.99 (negative FCF - burning cash) (Net Debt 29.6m / FCF TTM -29.8m)
Total Stockholder Equity = 829.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.81% (Net Income 50.3m / Total Assets 1.05b)
RoE = 6.07% (Net Income TTM 50.3m / Total Stockholder Equity 829.1m)
RoCE = 6.37% (EBIT 57.2m / Capital Employed (Equity 829.1m + L.T.Debt 69.4m))
RoIC = 6.72% (NOPAT 42.3m / Invested Capital 628.7m)
WACC = 7.79% (E(131.7m)/V(224.4m) * Re(11.94%) + D(92.7m)/V(224.4m) * Rd(2.57%) * (1-Tc(0.26)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.13%
Fair Price DCF = unknown (Cash Flow -29.8m)
EPS Correlation: -5.86 | EPS CAGR: -52.77% | SUE: -0.30 | # QB: 0
Revenue Correlation: -13.48 | Revenue CAGR: -33.12% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.45 | Chg30d=+0.060 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.06 | Chg30d=-0.134 | Revisions Net=-2 | Growth EPS=-23.6% | Growth Revenue=+0.2%
Additional Sources for EHTH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle